ALKBH5 and hepatocellular carcinoma: As EdU and CCK8 assays showed, overexpression of ALKBH5 decreased the proliferation capacity in 2 HCC cell lines, while co-overexpressed of PAQR4 reverted this phenomenon (Additional file 3A and B).